John Mascola, America’s soft-spoken, no-nonsense chief vaccinologist, spent 2020 on the fourth floor of the Vaccine Research Center in Bethesda, MD, primarily working on three projects....
In a time of uncertain market futures, when increased volatility is the rule of the day, it’s only natural to seek out expert advice. The only...
Each dose of Pfizer has a long and complex path involving mixing, storage at temperatures colder than the South Pole and specific protocols that must be...
India's drug regulator granted emergency use approval for Zydus Cadila's Covid-19 vaccine, the world's first DNA shot against the coronavirus, in adults and children aged 12...
Each dose of Pfizer vaccine has a long and complex path involving mixing, storage at temperatures colder than the South Pole and specific protocols that must...
Research published in Trends in Genetics by Dr. Leslie Lyons, Gilbreath-McLorn endowed professor of comparative medicine at the University of Missouri College of Veterinary Medicine, could be instrumental...
The Right To Bodily Integrity: Nobody Wins And We All Lose In The COVID-19 Showdown Authored by John W. Whitehead & Nisha Whitehead via The Rutherford...
By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT VolitionRx (NYSE: VNRX) is engaged in multiple epigenetic projects based on company's proprietary Nu.QTM platform...
As the Delta variant drives a global surge in Covid-19 cases, the Coalition for Epidemic Preparedness Innovations (CEPI) is investing $20.6 million in Gritstone’s efforts to...
Scientists have used an adaptation of the genome editing technology CRISPR to develop a new tool that can identify antibodies to SARS-CoV-2 in patient blood samples....
Spatial biology is among the smaller segments of the broader life sciences market. In GEN’s first-ever top-10 A-List for spatial biology biology there are five of...
With the health care industry coming into focus again, these biotech stocks could be worth considering. The post Best Biotech Stocks To Watch In 2021? 4...
Here are four steps to consider now for a more successful, secure retirement. Post pandemic, it appears that a successful and secure retirement is becoming more...
Last year, as coronavirus stocks became a thing, Inovio Pharmaceuticals (INO) was one of the early front runners, and investors pinned hopes on the biotech’s potential...
SARS-Cov-2 has experienced roughly the same amount of evolutionary change during the pandemic as humans have since Homo habilis first walked the Earth about 2.5m years...
Months after landing a massive SPAC deal that carried Ginkgo Bioworks to the Nasdaq, the company is touting a manufacturing breakthrough from partner Aldevron for mRNA vaccine...
Being immunocompromised appears to affect the vaccine response, but this seems to vary depending on the causes of the person’s low immunity.
In a review of recently published scientific studies, investigators at Keck School of Medicine of USC identified a natural barrier to the inner’s sensory cells’ ability to...
Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.
The two companies are collaborating in the development of mRNA vaccines for SARS-CoV-2 and seasonal influenza, but the deal signals Sanofi's desire to advance the mRNA...
Translate Bio is partnering with Sanofi in developing MRT5500, an mRNA vaccine based on Translate’s proprietary MRT™ platform, which it acquired from Shire in 2017.
Which biotech stocks on the TSX and TSXV have performed the best so far this year? Here's a look at three top Canadian biotech stocks.
When three companies emerged in the winter of 2020 promising that a fancy new technology called mRNA could pull the world out of a deadly pandemic,...
With the rising concern of COVID-19, should you check out these medical diagnostic stocks? The post 4 Medical Diagnostic Stocks To Watch Next Week appeared first...
Simona King → Back in May, Passage Bio CFO Richard Morris and CMO Gary Romano left within days of each other, but this week the gene...
Congenica CEO David Atkins recently took time to chat with Clinical OMICs Editor in Chief Chris Anderson about the company’s plans and his views of the...
But heavy users of conservative media have less confidence and are more likely to believe in conspiracy theories Credit: Annenberg Public Policy Center of the University...
Could this exciting frontier of the biotech industry be worth jumping on now? The post 5 Top Synthetic Biology Stocks To Watch This Week appeared first...
Researchers at the Technical University of Munich have developed a method to create tiny virus traps that can bind viral particles and render them harmless within...
Scientists collaborate to model the complex protein responsible for SARS-CoV-2 replication, revealing its potential weak spots for drug development Credit: Greg Hura/Berkeley Lab In February 2020,...